Trials / Conditions / Glycogen Storage Disease Type V
Glycogen Storage Disease Type V
6 registered clinical trials studyying Glycogen Storage Disease Type V.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Withdrawn | Biomarker for Glycogen Storage Diseases (BioGlycogen) NCT02385162 | CENTOGENE GmbH Rostock | — |
| Completed | MRI in McArdle Disease (GSDV) NCT03844022 | Rigshospitalet, Denmark | — |
| Completed | Triheptanoin in Mc Ardle NCT02919631 | Institut National de la Santé Et de la Recherche Médicale, France | Phase 2 |
| Unknown | Fat and Sugar Metabolism During Exercise in Patients With Metabolic Myopathy NCT02635269 | Rigshospitalet, Denmark | N/A |
| Completed | The Effect of Triheptanoin in Adults With McArdle Disease (Glycogen Storage Disease Type V) NCT02432768 | Rigshospitalet, Denmark | Phase 2 |
| Completed | Sodium Valproate for GSDV NCT03112889 | University College, London | Phase 2 |